Xofigo®(radium-223 dichloride)
Dosing and Administration
Xofigo has a fixed course of treatment
Treat for all 6 cycles of Xofigo to maximise overall survival benefit
- Xofigo is administered as a 1-minute IV injection every 4 weeks for 6 injections.
- Standard bloodwork required prior to every dose.
Help your patients experience the benefits of Xofigo
SIGNIFICANTLY EXTENDED MEDIAN OS BY 3.6 MONTHS VS PLACEBO
XOFIGO A PROLONGED TIME TO FIRST SSE BY 5.8 MONTHS VS PLACEBO
SLOWER DECLINE IN QoL WHILE ON TREATMENT VS PLACEBO
Use of Xofigo is not recommended in patients with low levels of osteoblastic bone metastases.
Abbreviations
OS, overall survival; SSE, symptomatic skeletal event; QoL, quality of life.
PP-XOF-IE-0131-1 | February 2026
▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professional are asked to report any suspected adverse reactions.